Lexeo Therapeutics Inc. (LXEO)
NASDAQ: LXEOHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 3.31 0.00%
LXEO stock chart
Technical analysisKey statistics
All statistics- Market cap
- $271.71M
- EPS (TTM)
- -$1.02
- Dividend yield
- None
- 52-week range
- 2.98 – 10.99
- Day range
- 3.22 – 3.46
- Volume / Avg
- 1.20M / 1.17M
- Beta
- —
- Shares outstanding
- 82.09M
- Next earnings
- Nov 4, 2026
52-week range
LXEO stock today
Lexeo Therapeutics (LXEO) closed at $3.31 on Oct 7, up 0.30% (+$0.01), versus the S&P 500's 0.22% decline. At this level, LXEO sits near the bottom of its 52-week range of $2.98 to $10.99: 69.9% below the high, set on Dec 23, 2025 and 11.1% above the low. LXEO is down 66.7% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 60.3%.
Lexeo Therapeutics has posted a net loss over the last twelve months (EPS of -$1.02), so its P/E ratio is not meaningful. Lexeo Therapeutics's next earnings report is expected on Nov 4, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Lexeo Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- IPO year
- 2023
Earnings
Earnings history- Next report
- Nov 4, 2026
- EPS estimate
- $-0.33
Lexeo Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| IKTInhibikase Therapeutics Inc. | 1.94 | -2.02% | $270.70M | vs LXEO |
| XFORX4 Pharmaceuticals Inc. | 2.81 | +1.44% | $278.60M | vs LXEO |
| SABSSAB Biotherapeutics Inc. | 2.88 | -1.71% | $262.04M | vs LXEO |
| PALIPalisade Bio Inc. | 1.48 | -0.67% | $257.92M | vs LXEO |
| FATEFate Therapeutics Inc. | 2.15 | -6.11% | $257.61M | vs LXEO |
| SRZNSurrozen Inc. | 25.15 | -4.65% | $295.54M | vs LXEO |
| STROSutro Biopharma Inc. | 14.66 | +1.45% | $243.08M | vs LXEO |
| LCTXLineage Cell Therapeutics Inc. | 0.9476 | +1.03% | $239.66M | vs LXEO |
Indexes, lists and sector
Lexeo Therapeutics stock FAQ
What is Lexeo Therapeutics's stock price today?
LXEO last traded at $3.31 as of Oct 7, 4:00 PM EDT, up 0.30% on the day. Prices are delayed at least 15 minutes.
When is Lexeo Therapeutics's next earnings date?
Lexeo Therapeutics is expected to report earnings on Wednesday, November 4, 2026. Analysts expect EPS of $-0.33.
What is the LXEO 52-week high?
The 52-week high for LXEO is $10.99 and the 52-week low is $2.98. The stock is currently 69.9% below its high.